In this study, we characterized a Tunisian family ( Figure  1 ) with RP with an unknown, but probable, autosomal recessive mode of inheritance. To determine if the family was linked to one of the known arRP genes, two microsatellite markers were selected from the known genes and loci of arRP and used to genotype the members of this family. After linkage analysis, we excluded all arRP genes but the CRB1 locus. Mutation screening of the 12 exons and splice sites of CRB1 gene revealed a novel homozygous missense mutation.
METHODS
To assess the molecular origins of RP/LCA in Tunisia, 156 patients belonging to 67 families were enrolled. Among this cohort, 87 (36 females and 51 males) were affected and 69 (43 females and 26 males) were healthy. As recruitment of patients was not based on appearance of symptoms, the age of affected and non -affected individuals varied from less than 2 years to over 70 years. Accessible members were clinically assessed and underwent complete ophthalmic examination, including best-corrected visual acuity (BCVA) with Snellen chart and illiterate E chart, slit-lamp biomicroscopy, and fundus photography. In the proband, fluorescein angiography was performed (fundus camera: FA IMAGEnet, Topcon Corporation, Tokyo, Japan). Blood samples were obtained from participating family members after informed consent was received in compliance with the Declaration of Helsinki for research involving human subjects. The study was approved by the Hedi Rais Institute of Ophthalmology.
DNA extraction: Total human genomic DNA was isolated with the DNA isolation Kit for Mammalian Blood (Nucleon Bacc2 genomic DNA Extraction, Amersham RPN 8502, GE Healthcare, Glattbrugg Switzerland). Linkage and haplotype analyses were  used to test linkage of the family to 19 arRP loci, including  CRB1, ABCA4, LRAT, USH2A, RP29, CERKL, CNGA1,  CNGB1, EYS, FAM161A, SAG, MERTK, NR2E3, PDE6A,  PDE6B , RGR, RHO, RLBP1, and TULP1. Microsatellite markers flanking these loci were selected from (Appendix 1), amplified with PCR, and genotyped using an ABI 3100XL Genetic Analyzer (Applied Biosystems, Foster City, CA; with the Gene Mapper 2.5 software program from Applied Biosystems). Haplotypes were constructed by hand and checked for homozygosity.
Haplotype analysis:
Mutation screening: Primer3 (v. 0.4.0) software was used to designed oligonucleotides primers from the DNA sequence of CRB1. These primers covered all the exons and splice junctions of CRB1, including the promoter (Table 1) . Twelve exons and splice sites were analyzed in the proband after PCR amplification with the following conditions: initial denaturation for 5 min at 95 °C, followed by 35 cycles of denaturation at 94 °C for 1 min, annealing at 60 °C for 1 min, extension at 72 °C for 1 min, and final extension at 72 °C for 10 min. Amplicons were directly sequenced on an ABI 3100XL DNA sequencer, using the Big Dye Terminator Labeling Kit version 1 (Life Technologies, Zug, Switzerland). The frequency of the mutation was checked in 96 ethnically matched controls and in 96 Caucasian controls.
RESULTS

Clinical findings:
The proband (II:1) was born to unrelated parents, and their marriage was not consanguineous ( Figure  1 ). The primary symptom of vision problems, reduced visual acuity, occurred at the age of 37 years, and she was 40 when she came for her first ophthalmic visit at the Institute. At that time, BCVA was 20/63 in the right eye and 20/80 in the left. The anterior segment was normal in both eyes. There was no cataract or refractive error. Funduscopic examination and fluorescein angiography revealed typical advanced retinal changes with bone spicule-like pigment deposits in the posterior pole and the midperiphery along with atrophy, narrowing of the vessels, and waxy optic discs ( Figure 2 ). No additional symptoms or ocular defects such as strabismus or nystagmus were observed in the proband. Her husband and both children were clinically examined. No abnormalities were found in all three individuals. Visual acuities were 10/10, and fundus photography was normal except in the boy, who presented hypertrophy of the pigment epithelium in the temporal superior quadrant of the left eye.
Molecular analysis: Mutation analysis for autosomal recessive RP did not reveal any previously reported mutation.
Following these results, we tested the most frequent arRP loci and genes by linkage in 14 families compatible with LCA out of a cohort of 67 families. Haplotype analysis revealed homozygosity in five families with microsatellite markers D1S412 and D1S413 on chromosome 1, two markers flanking CRB1. Our analysis excluded linkage of the other arRP loci/ genes. Sequencing all the exons and intron-adjacent regions of CRB1 in the probands of these families did not identify any mutation, except the one family reported here. In that family, sequencing CRB1 disclosed a missense homozygous mutation in exon 7 at nucleotide c. 2291G>A, resulting in the substitution of histidine (His) for arginine (Arg) at position 764 (p.Arg764His; Figure 3) . Examination of the pathogenicity of the Arg764His mutation with PolyPhen generated a score of 0.975 (probably damaging), close to the maximum value of 1.00, while Sorting Intolerant From Tolerant (SIFT) predicted a tolerated change with a score of 0.15. This mutation was not observed in 96 ethnically matched controls or in 96 Caucasian individuals. Alignment of CRB1 showed that R764 was conserved among various species, from apes to Caenorhabditis elegans. However, in several mammals, including the dog, rat, and mouse, R764 was not conserved. In these three species, the basic amino acid was changed to a hydrophobic (cysteine) or polar (serine) amino acid ( Figure 4 ).
DISCUSSION
Mutations in CRB1 have been reported in patients with LCA [7, 8] , in two forms of retinitis pigmentosa, with or without preservation of the para-arteriolar retinal pigment epithelium [9] and in RP with Coats-like exudative vasculopathy [10, 11] . CRB1 is expressed in the human retina, brain, and fetal brain, and CRB1 is an extracellular protein with a signal peptide, 19 epidermal growth factor-like domains and three laminin A G-like domains and C-type lectin (CTL) domain [12] ( Figure 5 ). These domains interact with other extracellular or transmembrane proteins [13] . CRB1 regulates the polarity of epithelial cells by participating in assembling the zonula adherens region. In Drosophila, defects in crb cause an abnormal shape of the photoreceptors, and in the mouse, a frameshift mutation at nucleotide 3481 causes the rd18 phenotype. To date, more than 70 missense/nonsense mutations have been identified in CRB1 in patients with retinal dystrophies, and 19 variants have been reported associated with RP12 (HGMD) [14] . All these mutations map on the extracellular domain precisely on the epidermal growth factor-and laminin A G-like domains [3] . These domains are conserved from flies to mammals [13] . The Arg764His mutation is localized on the second laminin A G-like domain ( Figure 5 ). This domain is an 180-amino-acid-long domain found in a large and diverse set of extracellular proteins [15, 16] . Laminin AG-containing proteins appear to have a wide variety of roles in cell adhesion, signaling, migration, assembly, and differentiation [17] . The CRB1 protein is located at the level of the photoreceptor inner segment more precisely at the adherens junctions that connect rod and cones photoreceptor cells with each other and with Müller glial cells [18] . As CRB1 is inserted through the cell membrane, this protein probably serves important functions inside and outside the photoreceptor cell. The 37-aminoacid cytoplasmic segment is known to act as an anchor for several proteins, such as MPP5 or PALS1 [19] . p.Arg764His is a novel CRB1 mutation and represents the first homozygous mutation described in a patient originating from North Africa associated with arRP. This mutation also represents the second missense mutation at residue R764 [3, 20] . The p.Arg764His mutation is most likely pathogenic as mutations in codon 764 generating cysteine mutants have already been reported. In addition, the p.Arg764His mutation was not found in 96 ethnically matched or in 96 European control individuals, and strong pathogenicity was predicted by PolyPhen. Interestingly, SIFT predicted a tolerated change. This may be because R764 was not conserved in the rat, dog, and mouse. In these first two species, arginine is replaced by cysteine, the same change observed by den Hollander et al. and Henderson et al. in five patients [3, 11, 20] . All patients were compound heterozygotes: three with an S403X and one with an E995X mutation. The second mutation was not found in the last patient. In addition to RP, three of these patients had Coats-like exudative vasculopathy. Genotypephenotype correlations are difficult to establish for CRB1 mutants. However, three out of four patients with a first missense mutation at codon R764 had a null second allele. This is in contrast with the patient we described. Lack of haploinsufficiency and the presence of two missense alleles may be responsible for the late-onset retinopathy observed in this patient.
Although we have not been able to document consanguinity between the parents of the proband, it is unlikely that these two alleles originated from independent mutations as the proband displayed a homozygous chromosomal region that was at least 4.6 Mb in length. Homozygosity mapping may therefore still be used in specific ethnic backgrounds despite a lack of overt consanguinity.
Precise identification of the molecular mutations in patients with arRP is important for genetic counseling and for future therapies. Loss-of-function mutations in slowdeveloping RP will most likely be among the first to benefit from gene therapy as already shown for RPE65. Patients such as the one described here might be good candidates for such treatment.
APPENDIX 1: LIST OF GENES/LOCI AND FLANKING MARKERS.
To access the data, click or select the words "Appendix 1." Figure 5 . Schematic representation of the crumbs homolog 1 gene with retinitis pigmentosa-causing mutations. The reported mutation is in bold.
